The AI algorithm, developed through a collaboration between AstraZeneca and Indian health-tech company Qure.ai, analyed scans conducted in Asia, the Middle East, Africa, and Latin America - regions ...

AstraZeneca has doubled down on plans to grow its US business as it braces for the country’s potential tariffs on the pharmaceutical industry. The drug maker said it is "firmly committed to investing ...

It does not necessarily reflect the view of The Herald. AstraZeneca has doubled down on plans to grow its US business as it braces for the country’s potential tariffs on the pharmaceutical industry.

AstraZeneca has doubled down on plans to grow its US business as it braces for the country’s potential tariffs on the pharmaceutical industry. The drug maker said it is “firmly committed to ...

(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) reported Tuesday that its first-quarter profit climbed from last year on sales growth. Further, the company reitereated its fiscal 2025 ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said: "Our strong growth momentum has continued into 2025 and we have now entered an unprecedented catalyst-rich period for our company.

The United States is a key market for the pharmaceutical industry, and AstraZeneca had already planning to invest $3.5 billion there by the end of 2026. Soriot said earlier in the year that he ...

Options include Prevacid 24HR (lansoprazole), Nexium 24HR (esomeprazole), Prilosec OTC (omeprazole), and Zegerid OTC (omeprazole, sodium bicarbonate). PPIs block an acid-producing enzyme in the ...